ReviewInformatics in medicine unlocked2023
COVID-19 Vaccines: Computational tools and Development.
Review in Informatics in medicine unlocked, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Review
- Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases.Pharmaceutics · 2024Review
- Role of Vaccination Strategies to Host-Pathogen Dynamics in Social Interactions.Entropy (Basel, Switzerland) · 2024Article
- Intranasally Inoculated SARS-CoV-2 Spike Protein Combined with Mucoadhesive Polymer Induces Broad and Long-Lasting Immunity.Vaccines · 2024Article
- Immunoinformatics design of a structural proteins driven multi-epitope candidate vaccine against different SARS-CoV-2 variants based on fynomer.Scientific reports · 2024Article
- Prevalence of extracorporeal blood purification techniques in critically ill patients before and during the COVID-19 pandemic in Egypt.Acute and critical care · 2024Article
- Immunoinformatics study to explore dengue (DENV-1) proteome to design multi-epitope vaccine construct by using CD4+ epitopes.Journal, genetic engineering & biotechnology · 2023Article
- Evolution of Status of Trace Elements and Metallothioneins in Patients with COVID-19: Relationship with Clinical, Biochemical, and Inflammatory Parameters.Metabolites · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The 2019 coronavirus outbreak, also known as COVID-19, poses a serious threat to global health and has already had widespread, devastating effects around the world. Scientists have been working tirelessly to develop vaccines to stop the virus from spreading as much as possible, as its cure has not yet been found. As of December 2022, 651,918,402 cases and 6,656,601 deaths had been reported. Globally, over 13 billion doses of vaccine have been administered, representing 64.45% of the world's population that has received the vaccine. To expedite the vaccine development process, computational tools have been utilized. This paper aims to analyze some computational tools that aid vaccine development by presenting positive evidence for proving the efficacy of these vaccines to suppress the spread of the virus and for the use of computational tools in the development of vaccines for emerging diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.